Skip to main content

Table 11 Use of urine β-subunit core fragment as a tumor marker for detection of malignancies.

From: New discoveries on the biology and detection of human chorionic gonadotropin

Malignancy Patients Sensitivity (> 3 fmol/ml)
Healthy no history of malignancy 97 9.3%
Healthy benign disease 159 6.9%
TOTAL 256 7.8%
Ovarian cancer 106 68%
Cervical cancer 89 46%
Endometrial cancer 110 51%
Pancreatic cancer 29 55%
Bladder cancer 102 48%
Lung cancer 122 24%
TOTAL 558 47%